Mitsubishi UFJ Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-47,755
| Closed | -$163K | – | 1596 |
|
2024
Q3 | $163K | Sell |
47,755
-4,499
| -9% | -$15.3K | ﹤0.01% | 984 |
|
2024
Q2 | $244K | Buy |
52,254
+30,575
| +141% | +$143K | ﹤0.01% | 940 |
|
2024
Q1 | $161K | Sell |
21,679
-993
| -4% | -$7.37K | ﹤0.01% | 980 |
|
2023
Q4 | $215K | Sell |
22,672
-6,715
| -23% | -$63.6K | ﹤0.01% | 1002 |
|
2023
Q3 | $229K | Hold |
29,387
| – | – | ﹤0.01% | 1007 |
|
2023
Q2 | $242K | Buy |
29,387
+4,678
| +19% | +$38.5K | ﹤0.01% | 1019 |
|
2023
Q1 | $179K | Buy |
24,709
+1,756
| +8% | +$12.7K | ﹤0.01% | 1035 |
|
2022
Q4 | $194K | Sell |
22,953
-74
| -0.3% | -$625 | ﹤0.01% | 1022 |
|
2022
Q3 | $282K | Buy |
23,027
+367
| +2% | +$4.49K | ﹤0.01% | 986 |
|
2022
Q2 | $268K | Buy |
22,660
+13,721
| +153% | +$162K | ﹤0.01% | 1010 |
|
2022
Q1 | $170K | Buy |
8,939
+1,009
| +13% | +$19.2K | ﹤0.01% | 1078 |
|
2021
Q4 | $219K | Sell |
7,930
-1,295
| -14% | -$35.8K | ﹤0.01% | 1068 |
|
2021
Q3 | $379K | Buy |
9,225
+220
| +2% | +$9.04K | ﹤0.01% | 978 |
|
2021
Q2 | $510K | Sell |
9,005
-3,879
| -30% | -$220K | ﹤0.01% | 953 |
|
2021
Q1 | $541K | Buy |
12,884
+4,227
| +49% | +$177K | ﹤0.01% | 876 |
|
2020
Q4 | $607K | Buy |
8,657
+1,529
| +21% | +$107K | ﹤0.01% | 811 |
|
2020
Q3 | $200K | Buy |
7,128
+88
| +1% | +$2.47K | ﹤0.01% | 896 |
|
2020
Q2 | $208K | Sell |
7,040
-100
| -1% | -$2.96K | ﹤0.01% | 888 |
|
2020
Q1 | $142K | Buy |
7,140
+1,456
| +26% | +$29K | ﹤0.01% | 893 |
|
2019
Q4 | $165K | Sell |
5,684
-670
| -11% | -$19.4K | ﹤0.01% | 902 |
|
2019
Q3 | $144K | Buy |
6,354
+1,109
| +21% | +$25.1K | ﹤0.01% | 868 |
|
2019
Q2 | $130K | Sell |
5,245
-452
| -8% | -$11.2K | ﹤0.01% | 889 |
|
2019
Q1 | $139K | Buy |
5,697
+537
| +10% | +$13.1K | ﹤0.01% | 843 |
|
2018
Q4 | $113K | Buy |
5,160
+1,314
| +34% | +$28.8K | ﹤0.01% | 830 |
|
2018
Q3 | $122K | Buy |
+3,846
| New | +$122K | ﹤0.01% | 829 |
|